894
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

FOXD4 induces tumor progression in colorectal cancer by regulation of the SNAI3/CDH1 axis

, , , , , & show all
Pages 1065-1071 | Received 23 Feb 2018, Accepted 20 May 2018, Published online: 25 Sep 2018

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. Ca Cancer J Clin. 2016;66(1):7. doi:10.3322/caac.21332.
  • Mellas N, Benbrahim Z, Mesbahi OE. Colorectal cancer: new developments after the 2013 ECCO/ESMO congress. Chin J Cancer. 2014;33(4):218.
  • Kopetz S, Chang GJ, Overman MJ, Eng C, Sargent DJ, Larson DW, Grothey A, Vauthey JN, Nagorney DM, Mcwilliams RR. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677. doi:10.1200/JCO.2008.20.5278.
  • Manisha V, Mona S, Durado B, Wender RC. Population-based programs for increasing colorectal cancer screening in the United States. Ca Cancer J Clin. 2015;65(6):496–510. doi:10.3322/caac.21295.
  • Chen W, Zheng R, Zeng H, Zhang S. The incidence and mortality of major cancers in China, 2012. Chin J Cancer. 2016;35(8):73. doi:10.1186/s40880-016-0137-8.
  • Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A. Cancer treatment and survivorship statistics, 2016. Ca Cancer J Clin. 2016;66(4):271. doi:10.3322/caac.21349.
  • Mellas N, Benbrahim Z, El MO. Colorectal cancer: new developments after the 2013 ECCO/ESMO congress. Chin J Cancer. 2014;33(4):218–221. doi:10.5732/cjc.013.10203.
  • Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490–1502.
  • Minoretti P, Arra M, Emanuele E, Olivieri V, Aldeghi A, Politi P, Martinelli V, Pesenti S, Falcone C. A W148R mutation in the human FOXD4 gene segregating with dilated cardiomyopathy, obsessive-compulsive disorder, and suicidality. Int J Mol Med. 2007;19(3):369–372(364).
  • Myatt SS, Lam EWF. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7(11):847–859. doi:10.1038/nrc2223.
  • Freyaldenhoven BS, Freyaldenhoven MP, Iacovoni JS, Vogt PK. Aberrant cell growth induced by avian winged helix proteins. Cancer Res. 1997;57(1):123–129.
  • Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta. 2009;1796(2):75.
  • Huber MA, Azoitei N, Baumann B, Grünert S, Sommer A, Pehamberger H, Kraut N, Beug H, Wirth T. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Investig. 2004;114(4):569. doi:10.1172/JCI200421358.
  • Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Investig. 2003;112(12):1776. doi:10.1172/JCI200320530.
  • Bates RC, Mercurio A. The epithelial-mesenchymal tansition (EMT) and colorectal cancer progression. Cancer Biol Ther. 2005;4(4):365–370. doi:10.4161/cbt.4.4.1655.
  • Neilson KM, Klein SL, Mhaske P, Mood K, Daar IO, Moody SA. Specific domains of FoxD4/5 activate and repress neural transcription factor genes to control the progression of immature neural ectoderm to differentiating neural plate. Dev Biol. 2012;365(2):363–375. doi:10.1016/j.ydbio.2012.03.004.
  • Du PJ, Newman M, Williams D. GATA3 immunohistochemical stain is a highly sensitive tool for distinguishing between upper urothelial tract urothelial carcinoma and lung squamous cell carcinoma and adenocarcinoma. Pathology. 2016;48:S67–S67. doi:10.1016/j.pathol.2015.12.168.
  • Kudo-Saito C, Shirako H, Takeuchi T, Kawakami Y. Cancer metastasis is accelerated through immunosuppression during Snail-induced EMT of cancer cells. Cancer Cell. 2009;15(3):195. doi:10.1016/j.ccr.2009.01.023.
  • Freyaldenhoven BS, Fried C, Wielckens K. FOXD4a and FOXD4b, two new winged helix transcription factors, are expressed in human leukemia cell lines. Gene. 2002;294(1–2):131. doi:10.1016/S0378-1119(02)00702-3.
  • Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature. 1993;364(6436):412–420. doi:10.1038/364412a0.
  • Lin L, Miller CT, Contreras JI, Prescott MS, Dagenais SL, Wu R, Yee J, Orringer MB, Misek DE, Hanash SM. The hepatocyte nuclear factor 3 alpha gene, HNF3alpha (FOXA1), on chromosome band 14q13 is amplified and overexpressed in esophageal and lung adenocarcinomas. Cancer Res. 2002;62(18):5273.
  • Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res. 2002;62(16):4773–4780.
  • Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, Jones M, Mason DY, Prime JE, Trougouboff P. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 2001;61(24):8820–8829.
  • Perreault N, Dutton-Sackett S, Lee CS, Mcnally S, Kaestner KH. The winged helix transcription factor foxa2 is required for the control of gastrointestinal epithelial cell proliferation. Gastroenterology. 2003;124(4):A277–A277. doi:10.1016/S0016-5085(03)81388-4.
  • Philip R, Heiler S, Mu W, Büchler MW, Zöller M, Thuma F. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer. Oncotarget. 2015;6(4):2046–2063. doi:10.18632/oncotarget.2858.
  • Wang SC, Lin XL, Wang HY, Qin YJ, Chen L, Li J, Jia JS, Shen HF, Yang S, Ry X. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway. Oncotarget. 2015;6(34):36713–36730. doi:10.18632/oncotarget.5457.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.